AC
COV

Andromeda Capital’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Andromeda Capital’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-41,160
Closed -$4.21M – 35
2014
Q4 		$4.21M Buy
+41,160
New +$3.95M 5.29% 8

Andromeda Capital's COV Position: Q1 2015 in Review

Andromeda Capital sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 41,160 shares — an estimated $4.21M sold.

Andromeda Capital first reported a position in COV in Q4 2014 and held it in 1 quarter. The position peaked at $4.21M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Andromeda Capital reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Andromeda Capital sold 41,160 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $4.21M.
  • Andromeda Capital first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014 and held it in 1 quarter.
  • Andromeda Capital's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $4.21M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Andromeda Capital's 13F filing for Q1 2015, filed 15 May 2015.